Search - tctmd.com

Displaying 1 - 20 of 3622

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

Are Bioresorbable Scaffolds Making a Comeback?

Presenter: Ajay Kirtane

November 13, 2025

Presentation Cardiovascular Interventions 2025

The Future of Drug Coated Balloons: Moving on to De Novo Disease?

Presenter: Suhail Dohad

November 13, 2025

Presentation TCT 2025

TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform

Presenter: Jared Romeo

October 28, 2025

Presentation TCT 2025

TCT 892: A prospective, open-labelled, multicentre, observational registry of ISAR SUMMIT in CAD patients undergoing PCI in real world Indian population.

Presenter: Sameer I. Dani

October 28, 2025

Presentation TCT 2025

TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.

Presenter: Bimmer E. Claessen

October 28, 2025

Presentation TCT 2025

TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice

Presenter: Adnan Kastrati

October 28, 2025

Presentation TCT 2025

TCT 888: DYNAMX Bioadaptor Implantation for Treatment of Complex Coronary Artery Disease – Final Results from The DYNAMITE Study

Presenter: Pier Pasquale Leone

October 28, 2025

Presentation TCT 2025

TCT 524: DCB-based versus DES-only Strategy for De Novo CAD across CHIP risk categories

Presenter: Dong Oh Kang

October 28, 2025

Presentation TCT 2025

Breakthrough Device Designation: Current Insights

Presenter: Todd J. Brinton

October 28, 2025

Presentation TCT 2025

TCT 1023: Comparative Effectiveness of DES, DCB, and BMS for the Treatment of In-Stent Restenosis in Carotid Artery Stents: A Systematic Review and Meta-Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 169: Patent Pending Ultra-Thin and Ultra-High-Pressure Balloon for Calcified Lesions (>100 atm) Using Specially Designed Carbon Fibers

Presenter: Mohammad Reza Movahed

October 28, 2025

Presentation TCT 2025

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Aditya Desai

October 28, 2025

Presentation TCT 2025

Stent Failure Through the Ages: BMS, First-Generation DES, and Beyond

Presenter: Gary S. Mintz

October 28, 2025

Presentation TCT 2025

TCT 108: Intracoronary Imaging Values As Alternative Approach to Evaluate Significant Ischemia at Proximal Left Descending Artery

Presenter: Satoshi Terashima

October 28, 2025

Presentation TCT 2025

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

Presenter: Gregg W. Stone

October 28, 2025

Presentation TCT 2025

The SmartWave Lithotripsy System for Valvular Heart Disease Treatment: Technology Description and Early Clinical Results

Presenter: Kent Chak-yu So

October 27, 2025

Presentation TCT 2025

The DragonFly T-TEER for Tricuspid Regurgitation: Technology Description and Clinical Results (Case in a Box)

Presenter: Jian'an Wang

October 27, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Presentation TCT 2025

TCT 288: The Diabetes Effect: Mortality Risk Persists in Cardiogenic Shock STEMI Despite Contemporary PCI

Presenter: Miles Chapman

October 27, 2025

Presentation TCT 2025

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Presenter: Rasha Al-Lamee

October 27, 2025

Advertisement

Are Bioresorbable Scaffolds Making a Comeback?

The Future of Drug Coated Balloons: Moving on to De Novo Disease?

TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform

TCT 892: A prospective, open-labelled, multicentre, observational registry of ISAR SUMMIT in CAD patients undergoing PCI in real world Indian population.

TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.

TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice

TCT 888: DYNAMX Bioadaptor Implantation for Treatment of Complex Coronary Artery Disease – Final Results from The DYNAMITE Study

TCT 524: DCB-based versus DES-only Strategy for De Novo CAD across CHIP risk categories

Breakthrough Device Designation: Current Insights

TCT 1023: Comparative Effectiveness of DES, DCB, and BMS for the Treatment of In-Stent Restenosis in Carotid Artery Stents: A Systematic Review and Meta-Analysis

TCT 169: Patent Pending Ultra-Thin and Ultra-High-Pressure Balloon for Calcified Lesions (>100 atm) Using Specially Designed Carbon Fibers

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Stent Failure Through the Ages: BMS, First-Generation DES, and Beyond

TCT 108: Intracoronary Imaging Values As Alternative Approach to Evaluate Significant Ischemia at Proximal Left Descending Artery

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

The SmartWave Lithotripsy System for Valvular Heart Disease Treatment: Technology Description and Early Clinical Results

The DragonFly T-TEER for Tricuspid Regurgitation: Technology Description and Clinical Results (Case in a Box)

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

TCT 288: The Diabetes Effect: Mortality Risk Persists in Cardiogenic Shock STEMI Despite Contemporary PCI

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content